Delivery Order SPE2DB22D3301-SPE2DB25FX3WQ

Award Date 10/17/24
Potential Completion Date 11/7/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price of $11,638.02 and a completion date of March 25, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply TASIGNA 150 MG CAPSULE 28S. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award, valued at $5,624.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a medication, to support military healthcare programs. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $16,873.86 firm fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a prescription medication. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH8BQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,819.01 firm-fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price contract. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,638.02 Firm Fixed Price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a specialty medication. The contract has an ultimate completion date of February 4, 2025 and was awarded on January 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product, with a performance period running through January 30, 2025. The contract was issued as a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $11,638.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product, and has a completion date of March 3, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX3WQ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $11,249.24 firm fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs. These contracts enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/16/25, 9:18 AM